title: Pharmacogenetics in immunosuppressive therapy: the best thing since TDM?
authors.affiliation: Department of Hospital Pharmacy, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands. t.vangelder@erasmusmc.nl
authors.forename: Teun
authors.initials: T
authors.lastname: van Gelder
authors.forename: Dennis A
authors.initials: DA
authors.lastname: Hesselink
authors.forename: Reinier M
authors.initials: RM
authors.lastname: van Hest
authors.forename: Ron A A
authors.initials: RA
authors.lastname: Mathôt
authors.forename: Ron
authors.initials: R
authors.lastname: van Schaik
mesh_terms: D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D010597:Pharmacogenetics
chemical_list: D007166:Immunosuppressive Agents